London · Delayed Price · Currency is GBP · Price in GBX Elixirr International Earnings Call Transcripts
Fiscal Year 2025
-
Delivered record revenue and EBITDA growth, driven by AI and strategic acquisitions, with strong cash generation and expanding client base. Diversification and employee ownership underpin resilience, while the outlook remains confident with continued organic and inorganic growth.
-
Delivered 35% revenue growth and 42% adjusted EBITDA increase in H1 2025, driven by organic expansion and the TRC acquisition. AI consulting and cross-sell revenues surged, while leverage and dilution remain modest, supporting ambitious FTSE 250 and long-term growth targets.
Fiscal Year 2024
-
FY24 saw 30% revenue growth, 23% higher EBITDA, and strong cash generation, with continued diversification across services, geographies, and industries. The business is moving to the Main Market, maintains high employee ownership, and has record momentum into FY25.
-
Revenue grew 28% in H1 2024, with strong organic and cross-sell growth, and adjusted EBITDA up 23%. Diversification across industries and capabilities, robust cash generation, and disciplined M&A underpin a positive outlook, with FY revenue forecast at £104m–£110m.